Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema

PURPOSE: To investigate whether eyes with diabetic macular edema (DME) and central retinal thickness (CRT) >400 μm had better visual and anatomical outcomes compared to eyes with a CRT <400 μm when treated with intravitreal bevacizumab in a real-world setting. PATIENTS AND METHODS: Patients un...

Descripción completa

Detalles Bibliográficos
Autores principales: Mushtaq, Bushra, Crosby, Niall J, Dimopoulos, Antonios T, Lip, Peck Lin, Stavrou, Panagiota, El-Sherbiny, Samer, Yang, Yit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010623/
https://www.ncbi.nlm.nih.gov/pubmed/24812486
http://dx.doi.org/10.2147/OPTH.S56624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010623/
https://www.ncbi.nlm.nih.gov/pubmed/24812486
http://dx.doi.org/10.2147/OPTH.S56624

Ejemplares similares